Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 851,411 | 772,010 | 706,360 | 646,676 | 471,907 | 413,211 | 443,896 | 407,227 | 375,630 | 333,114 | 267,309 | 246,972 | 237,788 | 223,248 | 209,130 | 197,216 | 192,354 | 174,860 | 131,412 | 117,880 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $851,411K
= 0.00
The debt-to-assets ratio of Catalyst Pharmaceuticals Inc has consistently been 0.00 across all reporting periods from March 31, 2020, to December 31, 2024. This indicates that the company has not been using debt to finance its assets during these periods. A debt-to-assets ratio of 0.00 implies that the company's assets are primarily funded by equity rather than debt, which can be seen as a positive sign in terms of financial stability and lower financial risk. It suggests that Catalyst Pharmaceuticals Inc has been managing its capital structure in a conservative manner, relying more on its own funds rather than external debt to support its operations and investments.
Peer comparison
Dec 31, 2024